MarketCap
Facebook
X
Telegram
Galecto EV/EBITDA Ratio | GLTO
Annual EV/EBITDA Ratio Galecto
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.13 | 0.579 | 0.369 | -0.494 | -0.363 | 2.3 | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.3 | -0.494 | 0.585 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Brickell Biotech
BBI
|
-0.0814 | - | -5.38 % | $ 6.06 M |  USA |
 |
Applied Therapeutics
APLT
|
0.477 | - | - | $ 8.42 M | USA |
 |
ESSA Pharma
EPIX
|
-24.2 | - | - | $ 8.86 M |  Canada |
 |
Generation Bio Co.
GBIO
|
-0.5 | - | - | $ 344 M | USA |
 |
Clearside Biomedical
CLSD
|
-1.5 | - | - | $ 25.3 M | USA |
 |
Merus N.V.
MRUS
|
-10.5 | - | - | $ 5.78 B |  Niderland |
 |
RAPT Therapeutics
RAPT
|
0.534 | - | - | $ 2.36 B | USA |
 |
Annexon
ANNX
|
-3.14 | $ 4.0 | -7.62 % | $ 620 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
77.8 | $ 156.5 | -2.85 % | $ 20.5 B | USA |
 |
Amgen
AMGN
|
13.3 | $ 462.71 | -3.3 % | $ 249 B | USA |
 |
Theratechnologies
THTX
|
17 | - | - | $ 83.9 M | Canada |
 |
Iovance Biotherapeutics
IOVA
|
-0.135 | $ 7.72 | -11.26 % | $ 2.76 M | USA |
 |
Biogen
BIIB
|
48.2 | $ 243.85 | -4.17 % | $ 35.7 B | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
-1.16 | $ 4.03 | 6.9 % | $ 652 M | USA |
 |
Armata Pharmaceuticals
ARMP
|
-17.1 | $ 3.01 | -4.14 % | $ 109 M | USA |
 |
Mustang Bio
MBIO
|
2.1 | $ 0.39 | -5.63 % | $ 1.91 M | USA |
 |
MannKind Corporation
MNKD
|
34.4 | $ 3.77 | -4.07 % | $ 1.15 B | USA |
 |
InflaRx N.V.
IFRX
|
-1.93 | $ 1.36 | -8.11 % | $ 91.5 M |  Germany |
 |
Immutep Limited
IMMP
|
-2.76 | $ 2.7 | -8.47 % | $ 3.93 B |  Australia |
 |
Insmed Incorporated
INSM
|
-26.4 | $ 108.79 | -1.1 % | $ 21.7 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
0.516 | - | -3.76 % | $ 3.47 M | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
-23.5 | $ 227.25 | -3.16 % | $ 13.9 B |  Irlanda |
 |
BioLineRx Ltd.
BLRX
|
-550 | $ 1.77 | -4.95 % | $ 4.36 B |  Israel |
 |
Bristol-Myers Squibb Company
BMY
|
45.8 | $ 63.15 | -1.64 % | $ 128 B | USA |
 |
Johnson & Johnson
JNJ
|
13.1 | $ 272.47 | -1.4 % | $ 656 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-1.22 | - | 3.16 % | $ 1.9 M | USA |
 |
PainReform Ltd.
PRFX
|
-0.255 | $ 0.76 | -1.27 % | $ 492 K | Israel |
 |
Kala Pharmaceuticals
KALA
|
0.0884 | $ 0.15 | -13.14 % | $ 1.22 M | USA |
 |
Prothena Corporation plc
PRTA
|
0.0485 | $ 7.9 | -5.84 % | $ 425 M | USA |
 |
TCR2 Therapeutics
TCRR
|
-0.615 | - | - | $ 58.1 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
2.14 | $ 14.53 | -1.63 % | $ 12.1 B |  India |
 |
Keros Therapeutics
KROS
|
3.77 | $ 9.42 | -13.02 % | $ 351 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
-8.07 | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
Kazia Therapeutics Limited
KZIA
|
-1.24 | $ 7.13 | -11.76 % | $ 109 M | Australia |
|
TFF Pharmaceuticals
TFFP
|
-0.366 | - | -60.05 % | $ 125 K | USA |
 |
Sana Biotechnology
SANA
|
-4.97 | $ 2.32 | -9.38 % | $ 588 M | USA |
 |
Lineage Cell Therapeutics
LCTX
|
-12.5 | $ 0.98 | -4.85 % | $ 226 M | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
31.2 | $ 298.8 | -5.48 % | $ 5.78 B | USA |
 |
Longeveron
LGVN
|
-750 | $ 1.76 | -1.12 % | $ 30.9 B | USA |
 |
Eli Lilly and Company
LLY
|
467 | $ 1 366.97 | -3.62 % | $ 1.23 T | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
-2.47 | - | -15.15 % | $ 60.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
-18.2 | - | - | $ 521 M | USA |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
-0.355 | $ 4.01 | -5.2 % | $ 48.9 M | Israel |
 |
Axcella Health
AXLA
|
-0.295 | - | -16.42 % | $ 249 M | USA |
 |
Compugen Ltd.
CGEN
|
3.32 | $ 1.94 | -4.68 % | $ 181 M | Israel |
 |
Liquidia Corporation
LQDA
|
-61 | $ 44.46 | -6.16 % | $ 3.83 B | USA |
 |
Sarepta Therapeutics
SRPT
|
-4.66 | $ 17.5 | -7.77 % | $ 1.75 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
4.01 K | - | - | $ 2.02 B | USA |
 |
Shattuck Labs
STTK
|
-6.35 | $ 4.46 | -11.84 % | $ 310 M | USA |
 |
Mesoblast Limited
MESO
|
-19.7 | $ 14.08 | -1.47 % | $ 17 B | Australia |